Saint Vincent and the Grenadines vs Suriname: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology

Saint Vincent and the Grenadines
0.2%
in 2024
Suriname
0.2%
in 2024
Saint Vincent and the Grenadines rank
98th
Suriname rank
98th

Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time

  • Saint Vincent and the Grenadines
  • Suriname
00.10.20.30.4201520192024

How they compare

Saint Vincent and the Grenadines currently reports 0.2% against 0.2% in Suriname, a difference of 0.0%.

The two have swapped places 1 time across 10 shared years of data; in 2015 it was Saint Vincent and the Grenadines ahead.

Saint Vincent and the Grenadines ranks 98th and Suriname ranks 98th of 246 countries.

Saint Vincent and the Grenadines has averaged higher in every one of the 2 decades both report.

Head to head by decade

Decade Saint Vincent and the Grenadines Suriname Difference Ahead
2010s 0.3% 0.2% 0.1% Saint Vincent and the Grenadines
2020s 0.2% 0.2% 0.0%

Averages of every year both report within each decade.

Frequently asked questions

Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Saint Vincent and the Grenadines or Suriname?
Saint Vincent and the Grenadines, at 0.2% against 0.2% in Suriname as of 2024.
What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Saint Vincent and the Grenadines and Suriname?
0.0%, with Saint Vincent and the Grenadines ahead.
How many years of comparable data are there for Saint Vincent and the Grenadines and Suriname?
10 years are reported by both, from 2015 to 2024.
How do Saint Vincent and the Grenadines and Suriname rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
Saint Vincent and the Grenadines ranks 98th and Suriname ranks 98th of 246 countries.
Where does this data come from?
United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Saint Vincent and the Grenadines vs Suriname: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology. Statizoid, drawing on United Nations Statistics Division, SDG Global Database. Retrieved 10 September 2026, from https://development-goals.statizoid.com/compare/prevalence-of-hepatitis-b-surface-antigen-hbsag-2026-methodology-percent/st-vincent-and-the-grenadines/suriname/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under UN SDG Global Database (open, attribution requested); please keep the attribution.

<a href="https://development-goals.statizoid.com/compare/prevalence-of-hepatitis-b-surface-antigen-hbsag-2026-methodology-percent/st-vincent-and-the-grenadines/suriname/">Saint Vincent and the Grenadines vs Suriname: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology</a> — Statizoid

About this data

Indicator
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%)
Unit
%
Source
United Nations Statistics Division, SDG Global Database
Licence
UN SDG Global Database (open, attribution requested)
Coverage
250 places, 2,500 data points, 2015–2024
Last refreshed